Ignite’s RPPA platform quantifies 32+ functional proteins and phosphoproteins from FFPE tissue, the same sample type routinely collected in clinical care. The platform is CLIA-certified, ...
Ignite will separate from Aditxt and is expected to become an independent public company called Ignite Proteomics.
Advancements in next-generation sequencing and mass spectrometry (MS) have transformed cancer research. Large-scale initiatives such as The Cancer Genome Atlas (TCGA), the International Cancer Genome ...
MOUNTAIN VIEW, Calif. & GOLDEN, Colo. & HONG KONG, June 09, 2026--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt"), a qualified acquisition corp and Ignite Proteomics, LLC ("Ignite", or "Ignite Proteomics"), a ...
A translational oncology research initiative by Prof. Stephan Singer at University Hospital Tübingen enables therapy selection, measuring more than 10,000 proteins in FFPE biopsies to reveal ...
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni â„¢ mass spectrometer to enable disease researchers to move beyond canonical protein ...
For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...
Researchers from the University of Science and Technology of China (USTC), led by Prof. Liu Qi, in collaboration with Harvard Medical School's Marinka Zitnik lab, have developed a novel deep ...
Protein functional annotation is crucial in biology, but many protein-coding genes remain uncharacterized, especially in non-model organisms. FANTASIA (Functional ANnoTAtion based on embedding space ...